Atea Pharmaceuticals

IPO

Atea Pharmaceuticals is a biotech company in Boston, United States, founded in 2014. It has raised $215.0M across 1 round, most recently a $215.0M Series D in May 2020.

Committed to the discovery, development and commercialization of oral direct-acting antiviral therapies.

Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$215.0M
Last Round
$215.0M Series DMay 2020
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

Atea Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing oral direct-acting antiviral therapies for serious viral diseases with unmet medical needs. Its lead program is a fixed-dose combination of bemnifosbuvir and ruzasvir in Phase 3 development for hepatitis C virus, with topline data from the C-BEYOND trial expected mid-2026. Atea also has early-stage programs targeting dengue and RSV.

Summary

It lists 51–200 employees. It has raised $215.0M in total across 1 round, most recently a $215.0M Series D round in May 2020. Investors include Bain Capital Life Sciences, RA Capital Management and Perceptive Advisors.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOOct 2020
$300.0M

Sign up to see all 2 events

Funding: Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Atea Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/atea-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/atea-pharmaceuticals" alt="Atea Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>